Meng Xiangqing, Wang Hongrui, Kuang Zhixuan, Wu Yujie, Su Xiaohui, Wang Jinyi, Li Ling, Liu Chang, Jia Min
Department of Chinese Medicine Authentication, Faculty of Pharmacy, Naval Medical University, 325 Guohe Road, Shanghai, 200433, China.
Heliyon. 2023 Aug 30;9(9):e19144. doi: 10.1016/j.heliyon.2023.e19144. eCollection 2023 Sep.
Viticis Fructus (called Manjingzi in China) is the dried ripe fruits of the plant species subsp. Steenis and L. in the family Lamiaceae. Viticis Fructus has been used as a traditional Chinese medicine for thousands of years to treat illness such as colds, headache, vertigo, anesthesia, and hyperkinesias. More chemical constituents and medicinal effects have been discovered in Viticis Fructus with the development of modern technology.: This review aims to analyze the research progress of Viticis Fructus from the aspects of botany, ethnopharmacology, phytochemistry, and pharmacological activity, as well as to provide an outlook on the research and use prospects of Viticis Fructus.
A comprehensive literature search using online databases such Science Direct, CNKI, Wiley online library, Spring Link, Web of Science, PubMed, Wanfang Data and SCI-Finder. In addition, information was obtained from local and foreign books on ethnobotany and ethnomedicine.
The application of Viticis Fructus as a medicine can be traced back to around 480 AD. So far, more than 190 compounds have been isolated from Viticis Fructus, including flavonoids, sterols, cyclic enol ether terpenoids, and diterpenoids. Modern pharmacological studies have shown that the extracts of Viticis Fructus have various pharmacological effects, such as anti-allergic, antioxidant, anti-inflammatory, anti-cancer, and anti-bacterial effects.
As a widely used traditional medicine, Viticis Fructus is rich in chemical compositions and has an obvious biological activity. However, the application and pharmacological activity of Viticis Fructus have not been scientifically evaluated or convincing due to poor methodology, unclear results and lack of clinical data. Systematic and comprehensive research evaluations are needed to verify its pharmaceutical activity, clinical therapeutic efficacy and safety. As an important herbal medicine, it should be further explored to facilitate the development of new medicines and treatments for a variety of diseases.
蔓荆子是唇形科植物单叶蔓荆Vitex rotundifolia L. f. subsp. simplicifolia Cham.和蔓荆Vitex trifolia L.的干燥成熟果实。蔓荆子作为中药已有数千年历史,用于治疗感冒、头痛、眩晕、麻醉和运动亢进等疾病。随着现代技术的发展,在蔓荆子中发现了更多化学成分和药理作用。本综述旨在从植物学、民族药理学、植物化学和药理活性等方面分析蔓荆子的研究进展,并对蔓荆子的研究和应用前景进行展望。
通过Science Direct、中国知网、Wiley在线图书馆、Springer Link、科学网、PubMed、万方数据和SCI-Finder等在线数据库进行全面的文献检索。此外,还从国内外关于民族植物学和民族医学的书籍中获取信息。
蔓荆子入药可追溯到公元480年左右。迄今为止,已从蔓荆子中分离出190多种化合物,包括黄酮类、甾醇类、环烯醚萜类和二萜类。现代药理学研究表明,蔓荆子提取物具有多种药理作用,如抗过敏、抗氧化、抗炎、抗癌和抗菌作用。
作为一种广泛应用的传统药物,蔓荆子化学成分丰富,具有明显的生物活性。然而,由于方法学欠佳、结果不明确以及缺乏临床数据,蔓荆子的应用和药理活性尚未得到科学评估或令人信服的验证。需要进行系统全面的研究评估,以验证其药理活性、临床治疗效果和安全性。作为一种重要的草药,应进一步探索,以促进多种疾病新药和新疗法的开发。